. (2024). Socioeconomic inequalities in accumulation of multimorbidity in England from 2019 to 2049: a microsimulation projection study. Lancet Public Health, 9, e231-e239. http://doi.org/10.1016/s2468-2667(24)00028-8
Humans
. (2024). A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases. Vaccine, 42, 3039-3048. http://doi.org/10.1016/j.vaccine.2024.03.043
. (2024). Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study. Int J Infect Dis, 140, 31-38. http://doi.org/10.1016/j.ijid.2024.01.002
. (2024). Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation. Rmd Open, 10. http://doi.org/10.1136/rmdopen-2023-003980
. (2024). Health Care Resource Utilization and Costs Associated With COVID-19 Among Pediatrics Managed in the Community or Hospital Setting in England: A Population-based Cohort Study. Pediatr Infect Dis J, 43, 209-216. http://doi.org/10.1097/inf.0000000000004213
. (2024). Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls. Lancet Rheumatol, 6, e156-e167. http://doi.org/10.1016/s2665-9913(23)00338-7
. (2024). The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med, 12, 225-236. http://doi.org/10.1016/s2213-2600(23)00414-9
. (2024). Risk of fractures in half a million survivors of 20 cancers: a population-based matched cohort study using linked English electronic health records. Lancet Healthy Longev, 5, e194-e203. http://doi.org/10.1016/s2666-7568(23)00285-4
. (2024). Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major Bleeding. Jama Netw Open, 7, e243208. http://doi.org/10.1001/jamanetworkopen.2024.3208
. (2024). Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK. Bmc Med, 22, 82. http://doi.org/10.1186/s12916-024-03283-5